相关实验视频

Updated: Jan 8, 2026

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

在大肠杆菌中进行基因组编辑的IV-A3型CRISPR-Cas系统的特性和工程

Szabolcs Semsey¹, Emilie Søndberg¹, Mathilde Røen¹

¹SNIPR Biome ApS, 2100, Copenhagen, Denmark.

Nucleic acids research

|December 19, 2025

概括

这项研究探讨了来自Klebsiella pneumoniae的未经探索的IV-A3型CRISPR-Cas系统,揭示了其通过在E. coli中实现向DNA断裂和基因编辑来实现基因工程的潜力.

科学领域:

微生物学微生物学
分子生物学分子生物学
基因组工程是基因组工程.

背景情况:

第四类CRISPR-Cas系统在很大程度上仍然没有特征,这限制了它们在基因组工程中的应用.
了解新的CRISPR-Cas系统对于扩大基因操纵工具包至关重要.

研究的目的:

为了描述Klebsiella pneumoniae的IV-A3型CRISPR-Cas系统.
调查其在Escherichia coli中的等离子体向,基因表达抑制和基因组工程方面的潜力.

主要方法:

一种IV-A3型CRISPR-Cas系统的识别和特征.
复杂构成中的系统子单位 (Csf1,Csf3,Csf4) 的功能分析.
通过融合效应器域来设计DNA裂变和基因编辑系统.
评估大肠杆菌中的基因编辑结果,包括IAA生产.

主要成果:

来自K. pneumoniae的IV-A3类型系统在大肠杆菌中表现出特征,显示出等离子体向和基因沉默能力.
Csf3 (Cas5) 对于复杂的形成至关重要,而Csf1和Csf4是不可缺少的.
该系统的等离子体抑制机制涉及DinG基酶活性和protospacer定位.
工程变异引入了有针对性的DNA断裂,并使基因编辑成为可能,包括通过托抑制基因失活来促进IAA生产.

结论:

这项研究阐明了IV-A3型CRISPR-Cas系统及其组件的机制.
工程类型IV-A3CRISPR-Cas系统显示出多种基因组工程应用的巨大潜力,包括向DNA裂变和基因编辑.
这项工作将CRISPR工具箱扩展到一个用于精确基因改造的新系统.

更多相关视频

Genome Editing in Mammalian Cell Lines using CRISPR-Cas

Genome Editing in Mammalian Cell Lines using CRISPR-Cas

Published on: April 11, 2019

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.

Published on: December 11, 2020

相关概念视频

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

Homologous Recombination

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...